Introduction. The Influence of diabetes mellitus in the tate outcome of cor
onary stenting remains controversial.
Aim. The aim of this study was to determine the late clinical outcome of di
abetics in comparison with non diabetics and to establish whether there are
subgroups of diabetic patients with a greater need for target lesion revas
cularization.
Methods. Two hundred sixteen consecutive patients (74 diabetics; 95 stents
in 90 lesions and 142 non diabetics) who had successfully undergone coronar
y stenting were included in the study and followed over 17.6 +/- 10 months.
The clinical events evaluated were target lesion revascularization, death
and acute myocardial infarction. independent predictive variables of target
lesion revascularization were studied in both groups of patients.
Results. The diabetic patients presented greater cardiovascular mortality (
6.7% vs 1.4%; p = 0.02) but the incidence of infarction was similar in the
two groups (2.7% vs 3.5%; p = 0.6). The accumulated rate of target lesion r
evascularization at two years was 18,2% in diabetics vs 13.3% in non diabet
ics (p = 0.09), respectively. The presence of three vessel disease (p = 0.0
14), history of arterial hypertension (p = 0.011) and residual stenosis > 0
% (p = 0.005) were specific predictive factors of target lesion revasculari
zation for diabetic patients and together with vessel diameter < 3 mm (p <
0.001) subgroups of diabetics were independently selected with a significan
tly greater incidence of target lesion revascularization than the non diabe
tic patients.
Conclusions. Following coronary stenting, diabetic patients show a greater
cardiovascular mortality than non diabetics, but only some subgroups of dia
betics (small vessels extensive coronary disease, associated arterial hyper
tension, residual stenosis) show a significantly greater risk of target les
ion revascularization.